Physician-only platform Doceree secured $35 M Series B funding from Creaegis
$35 million has been invested in Doceree, a network of physician-only platforms for programmatic messaging, in a Series B round that was spearheaded by Creaegis. Participating in the round were existing investors Eight Roads Ventures and F-Prime Capital.
Previously, in April of last year, it completed its Series A round, raising $11 million.
According to a press release from the company, the funds will allow Doceree to speed up product development, improve technologies, scale global expansion, and increase team size.
In order to improve patient health outcomes, four-year-old Doceree wants to equip pharmaceutical, life sciences, and healthcare media agencies with solutions that reach HCPs (healthcare professionals) on their networks.
“The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space,” said Harshit Jain MD, founder and global CEO, Doceree.
Doceree claims to have grown more than 100% in the past year, with monthly revenue increasing five times since the Series A round, even though it has not yet submitted its annual financial statement for FY23.
In order to expand into eight Southeast Asian nations, including Vietnam, Indonesia, Malaysia, Cambodia, Myanmar, Singapore, Philippines, and Taiwan, Doceree partnered with Hello Health Group in May.
Creaegis, a domestic private equity firm, recently closed its first fund at a cost of about $426 million. The fund plans to invest in 12 to 15 growth stage companies, and it will support about four new businesses every year. Among the companies in its portfolio are Medikabazaar, Zopper, and Kale Logistics.
